Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease [24] (multiple letters)

Circulation

Volumn 96, Issue 10, 1997, Pages 3805-3807

  Brattstrom, L ^a   Van Bockxmeer, F M ^a   Mamotte, C D S ^a   Vasikaran, S D ^a  

^a KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; GENE FREQUENCY; GENE MUTATION; HOMOZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; LETTER; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

CARDIOVASCULAR DISEASES; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; RISK FACTORS;

EID: 0030775334     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)